# A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

> **NCT04830826** · — · COMPLETED · sponsor: **The First Affiliated Hospital of Guangzhou Medical University** · enrollment: 1490 (actual)

## Conditions studied

- NSCLC, Stage I
- NSCLC, Stage II
- NSCLC, Stage III

## Interventions

- **PROCEDURE:** Surgeries

## Key facts

- **NCT ID:** NCT04830826
- **Lead sponsor:** The First Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-09
- **Primary completion:** 2024-07-08
- **Final completion:** 2025-04-07
- **Target enrollment:** 1490 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04830826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04830826, "A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04830826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*